Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 71-80 of 307 for infectious diseases

Edit search filters
  1. Continuous Glucose Monitor (CGM) Use in COVID-19 Patients

    Jacksonville, FL

  2. A Study to Evaluate MesilatE for Treating Hospitalized Patients with COVID-19 (Enrolling by Invitation Only)

    Jacksonville, FL, Scottsdale/Phoenix, AZ

  3. A Study Of Clofazimine For Treating Patients With Drug Resistant Non-Tuberculous Mycobacterial Infections

    Rochester, MN

  4. Benznidazole For Treatment Of Chagas Disease (American Trypanosomiasis)

    Scottsdale/Phoenix, AZ

  5. A Study to Evaluate At Home Administration of Pertuzumab Combined with Trastuzumab to Treat Patients with HER2-Positive Breast Cancer During COVID-19 Pandemic

    Jacksonville, FL, Rochester, MN

  6. Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)

    Rochester, MN

  7. Molecular Analysis of Blood for the Detection of Cardiovascular Pathogens

    Rochester, MN

  8. Silver-impregnated Suprapubic Catheters (SPC) in Urogynecology

    Rochester, MN

  9. A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)

    Rochester, MN

  10. A Multicenter Treatment Protocol Of Daclatasvir (BMS-790052) In Combination With Sofosbuvir For The Treatment Of Post-Liver Transplant Subjects With Chronic Hepatitis C

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer